Stock-Based Compensation - Schedule of Outstanding Stock Appreciation Rights (Details) - Stock appreciation rights - $ / shares	11 Months Ended	12 Months Ended
	Nov. 30, 2020	Dec. 31, 2019
SARs Outstanding:
Outstanding at beginning of period (in shares)	1,010,000
Vested and exercisable at beginning of period (in share)	606,250
Granted (in shares)	0
Vested (in shares)	198,750
Exercised (in shares)	0
Forfeitures (in shares)	0
Cancelled (in shares)	(805,000)
Outstanding at beginning of period (in shares)	0	1,010,000
Vested and exercisable at end of period (in shares)	0	606,250
Weighted Average Exercise Price Per Share:
Outstanding at end of period, weighted average exercise price per share (in dollars per share)	$ 6.30
Vested and exercisable at beginning of period, Weighted average exercise price (in dollars per share)	6.65
Granted, weighted average exercise price per share (in dollars per share)	0
Vested, weighted average exercise price per share (in dollars per share)	0
Exercised, weighted average exercise price per share (in dollars per share)	0
Forfeitured, weighted average exercise price per share (in dollars per share)	0
Cancelled, weighted average exercise price per share (in dollars per share)	6.79
Outstanding at end of period, weighted average exercise price per share (in dollars per share)	0	$ 6.30
Vested and exercisable at end of period, Weighted average exercise price (in dollars per share)	$ 0	$ 6.65
Weighted Average Remaining Contractual Term:
Outstanding, weighted average remaining contractual term (in years)		2 years 6 months
Options vested and exercisable, Weighted Average Remaining Contractual Term (in years)		2 years 4 months 24 days
Options cancelled, weighted average remaining contractual term (in years)	1 year 4 months 24 days